Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways

International Journal of Oncology
Zhi-Ping ZhouChun-Xiao Wang

Abstract

Golgi phosphorylated protein (GOLPH)3 is overexpressed in colorectal cancer tissues and promotes the proliferation of colon cancer cells. A previous study by the authors demonstrated that GOLPH3 was associated with poor prognosis in colorectal cancer. However, the association between GOLPH3 gene overexpression and resistance to platinum-based drugs in colon cancer remains unknown. In the present study, the association between GOLPH3 overexpression and resistance of HT29 colon cancer cells to cisplatin and the mechanism underlying the development of chemoresistance were investigated. HT29 cells were divided into five groups. The expression of GOLPH3 mRNA was measured in the control and siRNA transfection groups. Reverse transcription-quantitative polymerase chain reaction analysis, cell proliferation, colony formation assay, tumor sphere formation and apoptosis (Annexin V) assays, western blotting and a nude mouse tumorigenicity assay were performed. HT29 cells were resistant to 10 µM cisplatin treatment, whereas the expression of GOLPH3, P-glycoprotein, phosphorylated extracellular signal-regulated kinase (pERK)1/2 and β-catenin protein was significantly upregulated compared with the control group. With cisplatin treatment, sil...Continue Reading

References

Aug 29, 2013·International Journal of Cancer. Journal International Du Cancer·Stephanie B HatchRicky A Sharma
Nov 14, 2013·World Journal of Gastroenterology : WJG·Akram YusupGuo-Qing Zhang
Feb 4, 2014·Cell·Suzette E Farber-KatzSeth J Field
Jun 1, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stanleyson V HatoW Joost Lesterhuis
Sep 11, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yingchun MaXiaoxia Zheng
Jan 31, 2015·Cancer Research·Matthew D BuschmanSeth J Field
Feb 18, 2016·Cancer Chemotherapy and Pharmacology·Shahana Dilruba, Ganna V Kalayda
Mar 22, 2016·Experimental and Therapeutic Medicine·Liancheng LiuZhongtao Zhang
Jun 18, 2016·Journal of Cancer·Cheng-Zhi QiuXiao-Feng Yang
May 24, 2017·International Journal of Oncology·Bao-Yuan HuangChang-Qing Zeng

❮ Previous
Next ❯

Citations

Feb 7, 2020·International Journal of Molecular Sciences·Stefano SechiMaria Grazia Giansanti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.